Meet The Team
Jenna Baker, PhD
Co-Founder & CEO
A broadly trained scientist with research across multiple disciplines, Jenna brings more than 20 years of life science experience in the academic, private, and government sectors to Gypsy Basin Genomics. By combining her background in computational and functional genomics with her leadership experience, she is helping GBG translate clinically relevant genomic signatures into advances in personalized clinical care.
Joe brings over 25 years of global healthcare experience in oncology, infectious disease, and respiratory therapeutic areas. He led the introduction for Merck of the first HPV vaccine, Gardasil, and was responsible for the formation of numerous global research, commercial, & manufacturing partnerships. He is recognized for his many successes commercializing technologies and building new product markets.
Senior Strategy Advisor
David is a seasoned healthcare CEO and Combat Veteran with over 20 years of experience commercializing diagnostics. He has built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers. He was the CEO at Armune BioScience, which sold to Exact Sciences [EXAS] in Dec. 2017, as well as the US President at Phadia US/AB, which sold to Thermo Fisher Scientific [TMO] Sept. 2011).
Lynn has led the National Cervical Cancer Coalition, advocating for cervical health, vaccination, and HPV testing, as well as its parent organization, the American Sexual Health Association, as President and CEO since June 2006. She works closely with colleague organizations, from the American Sexual Transmitted Diseases Association, the National Coalition of STD Directors, and the Centers for Disease Control and Prevention.
Daniel Schoener, PhD
Senior R&D Advisor
Daniel is a business-driven R&D leader with years of experience in diagnostic product development. He has worked for Roche and Perkin Elmer in the EU and US and has been responsible for key product launches in various testing segments including Virology and Genomics. Daniel’s has a track record in the integration and commercial realization of several new technologies after company acquisitions in the PCR and NGS space.
Anna Giuliano, PhD
HPV Scientific Advisor
Dr. Giuliano is the Founding Director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center. Her work has contributed significantly to our understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, and also to HPV vaccine protection against multiple diseases in women and men.